How AstraZeneca Ruling Could Change Dosage Patent Claims
The U.S. District Court for the District of Delaware recently entered final judgment in Wyeth LLC v. AstraZeneca Pharmaceuticals LP, a patent infringement case relating to treatments for non-small cell lung cancer.[1]...To view the full article, register now.
Already a subscriber? Click here to view full article